The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis

Steffen Moritz, Fabrice Berna, Susanne Jaeger, Stefan Westermann, Matthias Nagel, Steffen Moritz, Fabrice Berna, Susanne Jaeger, Stefan Westermann, Matthias Nagel

Abstract

Clinicians and patients differ concerning the goals of treatment. Eighty individuals with schizophrenia were assessed online about which symptoms they consider the most important for treatment, as well as their experience with different interventions. Treatment of affective and neuropsychological problems was judged as more important than treatment of positive symptoms (p < 0.005). While most individuals had experience with Occupational and Sports Therapy, only a minority had received Cognitive-Behavioral Therapy, Family Therapy, and Psychoeducation with family members before. Patients appraised Talk, Psychoanalytic, and Art Therapy as well as Metacognitive Training as the most helpful treatments. Clinicians should carefully take into consideration patients' preferences, as neglect of consumers' views may compromise outcome and adherence to treatment.

Keywords: Psychosis; Schizophrenia; Treatment gap; Treatment preferences.

References

    1. Eur Psychiatry. 2015 Sep;30(6):709-14
    1. Nervenarzt. 2006 Nov;77(11):1301-2, 1304-9
    1. Schizophr Bull. 2006 Oct;32(4):765-75
    1. J Psychiatr Pract. 2012 Sep;18(5):321-8
    1. World Psychiatry. 2013 Oct;12(3):237-8
    1. Psychiatr Serv. 2001 Feb;52(2):214-8
    1. Psychol Med. 2002 Feb;32(2):347-58
    1. Early Interv Psychiatry. 2013 Feb;7(1):64-70
    1. Br J Psychiatry. 2014;204:333-4
    1. Hum Psychopharmacol. 2014 Sep;29(5):414-26
    1. Schizophr Res. 2009 Jun;111(1-3):61-9
    1. Soc Psychiatry Psychiatr Epidemiol. 2012 Jul;47(7):1035-45
    1. Schizophr Res Treatment. 2013;2013:457010
    1. Isr J Psychiatry Relat Sci. 2009;46(2):141-8
    1. Curr Med Res Opin. 2007 Oct;23(10):2305-12
    1. J Ment Health. 2014 Aug;23(4):162-5
    1. Schizophr Bull. 2013 Jul;39(4):917-22
    1. Psychiatr Serv. 2009 Aug;60(8):1107-12
    1. Behav Res Ther. 2011 Dec;49(12):901-7
    1. BMC Psychiatry. 2013 Feb 08;13:50
    1. Clin Psychol Psychother. 2011 Jan-Feb;18(1):48-59
    1. Psychiatr Prax. 2014 Jan;41(1):8-10
    1. J Clin Psychol. 2009 May;65(5):499-509
    1. Clin Psychol Rev. 2013 Aug;33(6):763-71
    1. Psychol Psychother. 2008 Dec;81(Pt 4):419-36
    1. Front Psychol. 2015 Sep 02;6:1294
    1. BMJ Open. 2015 Apr 08;5(4):e007848
    1. Br J Psychiatry. 2005 Dec;187:529-36
    1. Schizophr Res. 2012 Jan;134(1):20-6
    1. Psychiatr Serv. 2010 May;61(5):483-8
    1. PLoS One. 2014 Nov 13;9(11):e112348
    1. Am Psychol. 2004 Feb-Mar;59(2):93-104

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir